Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "BMO Research"


2 mentions found


A London-based hedge fund is betting against Cargojet , Canada's largest cargo airline, citing concerns about the company's aging fleet, accounting practices, and leadership style. Allen also claimed that the company has failed to update the age of its aircraft fleet. The Toronto-listed shares of the company have struggled this year, posting a 2% gain while the broader Canadian stock market has risen by nearly 25%. At the time of Allen's presentation slide titled "Cargojet is expensive," the stock was trading at 27 times earnings and 3.5 times tangible book value. In comparison, traditional airline Lufthansa trades at 7 times earnings, and United Airlines is valued at 9 times earnings estimate.
Persons: Edgar Allen, Ajay Virmani, Allen, they've, Cargojet, They've, Konark Gupta, Gupta, Allen's Sohn, Walter Spracklin, Fadi Chamoun, Chamoun, Drake, Elon Musk, Virmani Organizations: Cargojet, Investment Management, Sohn, United Parcel Service, Federal Express, CNBC Pro, CNBC, Scotiabank, RBC Capital Markets, BMO Research, Lufthansa, United Airlines, Elon Locations: London, Ontario, CJT, Toronto
CNN —Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. At least a dozen similar experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing. Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. The oral GLP-1 raceRight on the heels of oral semaglutide is a group of drugs led by Eli Lilly’s orforglipron, an oral medication that also targets GLP-1, which is a hormone implicated in insulin regulation, appetite and digestion. Drugmakers including Pfizer and Roche, as well as smaller companies like Structure Therapeutics, Terns Pharmaceuticals and Viking Therapeutics, also have oral weight-loss drugs in earlier stages of development, BMO research shows.
Persons: Jared Holz, ” Holz, , Jody Dushay, Dushay, ” Dushay, it’s, Rybelsus, Jorge Moreno, , ” Moreno, Eli Lilly’s orforglipron, Lilly, Evan Seigerman, amycretin, who’ve, Dr, Sanjay Gupta, Holz, he’s, he’d Organizations: CNN, Harvard Medical School, Beth Israel Deaconess Medical, Novo Nordisk, US Food and Drug Administration, Yale School of Medicine, BMO Capital Markets, Pfizer, Roche, Therapeutics, Terns Pharmaceuticals, Viking Therapeutics, BMO, Nordisk, European Association for, Diabetes, Inversago Pharma, CNN Health Locations: Danish, Novo
Total: 2